Boule Diagnostics Balance Sheet Health
Financial Health criteria checks 4/6
Boule Diagnostics has a total shareholder equity of SEK174.9M and total debt of SEK187.7M, which brings its debt-to-equity ratio to 107.3%. Its total assets and total liabilities are SEK480.8M and SEK305.9M respectively. Boule Diagnostics's EBIT is SEK26.8M making its interest coverage ratio 1.8. It has cash and short-term investments of SEK19.6M.
Key information
107.32%
Debt to equity ratio
SEK 187.70m
Debt
| Interest coverage ratio | 1.8x |
| Cash | SEK 19.60m |
| Equity | SEK 174.90m |
| Total liabilities | SEK 305.90m |
| Total assets | SEK 480.80m |
Recent financial health updates
We Think Boule Diagnostics (STO:BOUL) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...We Think Boule Diagnostics (STO:BOUL) Has A Fair Chunk Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Recent updates
BOUL: Leadership Transition And Revised Forecasts Will Shape Balanced Outlook
Analysts have lowered their price target on Boule Diagnostics to SEK 3.8 from SEK 7.5, citing updated assumptions for fair value, a higher discount rate, more conservative revenue growth and profit margin forecasts, and a higher future P/E multiple. What’s in the News for Boule Diagnostics Boule Diagnostics appointed Simonetta Tumbiolo, currently Chief Commercial Officer Diagnostic, as Interim Chief Executive Officer.Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
There's been a notable change in appetite for Boule Diagnostics AB (publ) ( STO:BOUL ) shares in the week since its...Boule Diagnostics AB (publ)'s (STO:BOUL) Revenues Are Not Doing Enough For Some Investors
With a price-to-sales (or "P/S") ratio of 0.4x Boule Diagnostics AB (publ) ( STO:BOUL ) may be sending very bullish...Boule Diagnostics AB (publ) (STO:BOUL) Shares Fly 31% But Investors Aren't Buying For Growth
Boule Diagnostics AB (publ) ( STO:BOUL ) shares have had a really impressive month, gaining 31% after a shaky period...We Think Boule Diagnostics (STO:BOUL) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...There's No Escaping Boule Diagnostics AB (publ)'s (STO:BOUL) Muted Revenues
With a price-to-sales (or "P/S") ratio of 0.7x Boule Diagnostics AB (publ) ( STO:BOUL ) may be sending very bullish...We Think Boule Diagnostics (STO:BOUL) Has A Fair Chunk Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Improved Revenues Required Before Boule Diagnostics AB (publ) (STO:BOUL) Stock's 26% Jump Looks Justified
Boule Diagnostics AB (publ) ( STO:BOUL ) shareholders would be excited to see that the share price has had a great...Does Boule Diagnostics (STO:BOUL) Have A Healthy Balance Sheet?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
It's been a mediocre week for Boule Diagnostics AB (publ) ( STO:BOUL ) shareholders, with the stock dropping 14% to...Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)
With a price-to-earnings (or "P/E") ratio of 15.7x Boule Diagnostics AB (publ) ( STO:BOUL ) may be sending bullish...Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
Last week saw the newest quarterly earnings release from Boule Diagnostics AB (publ) ( STO:BOUL ), an important...Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Boule Diagnostics is kr19.63 based on 2 Stage Free Cash Flow to Equity...Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results
Shareholders might have noticed that Boule Diagnostics AB (publ) ( STO:BOUL ) filed its yearly result this time last...Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch
It's not a stretch to say that Boule Diagnostics AB (publ)'s ( STO:BOUL ) price-to-earnings (or "P/E") ratio of 22.4x...Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Boule Diagnostics is kr23.35 based on 2 Stage Free Cash Flow to Equity Boule...Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals
Boule Diagnostics AB (publ)'s ( STO:BOUL ) robust earnings report didn't manage to move the market for its stock. Our...Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...Financial Position Analysis
Short Term Liabilities: BOUL's short term assets (SEK231.9M) exceed its short term liabilities (SEK216.6M).
Long Term Liabilities: BOUL's short term assets (SEK231.9M) exceed its long term liabilities (SEK89.3M).
Debt to Equity History and Analysis
Debt Level: BOUL's net debt to equity ratio (96.1%) is considered high.
Reducing Debt: BOUL's debt to equity ratio has increased from 40.9% to 107.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable BOUL has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: BOUL is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 11.1% per year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/27 16:22 |
| End of Day Share Price | 2026/07/27 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Boule Diagnostics AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| null null | ABG Sundal Collier Sponsored |
| Christian Lee | Pareto Securities |